Akers Biosciences (AKER) 3.22 $AKER
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 11:45AM CST
ALOG: 85.14 (-1.54), VBIV: 3.48 (-0.03), PRTK: 29.05 (+1.06), TPLM: 4.06 (-0.18), MIND: 5.92 (+0.17), SSE: 4.58 (-0.12), ALLT: 8.54 (+0.11), EGY: 4.49 (-0.06), GBR: 1.13 (+0.03), ECTE: 1.25 (-0.07), PWE: 2.15 (-0.06), GDP: 3.93 (-0.33), LAYN: 8.22 (+0.46), WRES: 1.32 (+0.03), CALA: 29.85 (+6.65), AKER: 3.22 (+0.05), CVEO: 7.81 (-0.15), CNIT: 4.30 (+0.09), CYRN: 1.80 (-0.16), CRK: 5.26 (-0.49)
Akers Biosciences Announces $1 Million Initial Order to Supply PIFA Heparin/PF4 Products to China
GlobeNewswire - Wed Dec 10, 6:00AM CST
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company"
, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces the receipt of an initial purchase order (the "Order" valued at US$1,000,000 from NovoTek Therapeutics Inc. ("NovoTek" to supply PIFA Heparin PF4/Rapid Assay products in Mainland China ("China" .
AKER: 3.22 (+0.05)
Update: My Discussion With RedChip And Thoughts Going Forward
Daniel Ward - at Seeking Alpha - Mon Dec 08, 8:08AM CST
XBI: 183.73 (-0.31), AKER: 3.22 (+0.05), AEZS: 0.60 (+0.03)
Cannabis (MMJ) Breathalyzer Could Follow Vertical Path of Alcohol Breathalyzer
ACCESSWIRE - Tue Dec 02, 8:40AM CST
Whitefish, MT / ACCESSWIRE / December 2, 2014 / The effects of alcohol on a driver are well documented, with motor skills and often decision-making skills decreasing with each drink, subsequently increasing the likelihood of a fatal accident. A field sobriety test (i.e. walking heel-to-toe, follow a pen with eyes, stand on one foot) typically does an ample job at helping police officers identify a driver under the influence of alcohol, which is then typically followed by the tried-and-true alcohol breathalyzer test to pinpoint blood alcohol concentration (BAC). Although some laws and penalties vary from state to state, there is a nationwide standard of drunk driving being defined as BAC at or above 0.08 percent. Technological advancements have made alcohol breathalyzers affordably available to businesses and consumers, like Akers Biosciences' (NASDAQ: AKER) CHUBE and BreathScan products, to estimate BAC. Another portable BAC estimator, Breathometer's eponymous device that operates by attaching it to the audio output of a smart phone, garnered an aggregate $1 million in investments from all five "sharks" in April on the popular CNBC show "Shark Tank," lending to the idea that it is a growing industry against the backdrop of stiffening laws and greater awareness. Breathometer isn't alone in the smart phone breathalyzer space, orders are being taken for FLOOME, a universal smartphone accessory for measuring BAC developed with the help of Proto Labs (NYSE: PRLB).
PRLB: 67.04 (-0.01), AKER: 3.22 (+0.05)
Horrendous Stock Performance Of RedChip Nation Healthcare And Biotech Stocks
Daniel Ward - at Seeking Alpha - Mon Dec 01, 10:29AM CST
INO: 8.49 (+0.27), AKER: 3.22 (+0.05)
RedChip Issues Research Update on Akers Biosciences
GlobeNewswire - Tue Nov 18, 7:40AM CST
RedChip Companies, Inc., today announced it has issued a research update on Akers Biosciences Inc. (Nasdaq:AKER), a leading designer and manufacturer of rapid diagnostic screening and testing products.
AKER: 3.22 (+0.05)
Akers Biosciences Net Loss of $1.12M
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 6:18AM CST
AKER: 3.22 (+0.05)
Akers Biosciences Announces Its Financial Results for Third Quarter 2014
GlobeNewswire - Thu Nov 13, 6:05AM CST
Akers Biosciences, Inc. (Nasdaq:AKER), (the "Company" or "ABI" , a leading designer and manufacturer of rapid diagnostic screening and testing products, reports its financial results for the third quarter ended September 30, 2014 and for the nine months ended September 30, 2014. The Form 10-Q containing the financial statements is available for viewing on the Company's website at www.akersbiosciences.com or www.sec.gov.
AKER: 3.22 (+0.05)
Akers Biosciences Announces Conference Call to Discuss Its Third Quarter and Nine Months Financial Results
GlobeNewswire - Mon Nov 10, 6:07AM CST
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI" , a leading designer and manufacturer of rapid diagnostic screening and testing products, will hold a conference call on Thursday, November 13, 2014, at 10:30 a.m. Eastern Time to discuss its results for the third quarter and nine months ended September 30, 2014.
AKER: 3.22 (+0.05)
The Perils Of Value Microcap Research And The Example Of Akers Biosciences
Daniel Ward - at Seeking Alpha - Tue Nov 04, 12:22PM CST
AKER: 3.22 (+0.05)
Week In Review: Roche Seeks China Partners With First-In-Class, Best-In-Class Products
ChinaBio Today - at Seeking Alpha - Sun Oct 26, 12:46PM CDT
Featured Companies In an exclusive interview, Dr. Darren Ji (Vice President and Global Head of Roche Partnering, Asia and Emerging Markets) told ChinaBio Today that Roche ( OTCQX:RHHBY ) ( OTCPK:RHHBF ) remains entirely focused on novel drugs for...
FMI: 21.52 (-0.31), AKER: 3.22 (+0.05), WX: 34.00 (+0.38)
Akers Biosciences Announces Joint Venture to Market Rapid Diagnostic Tests in China
GlobeNewswire - Thu Oct 23, 7:17AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers" , a leading designer and manufacturer of rapid diagnostic screening and testing products, has signed a Joint Venture Agreement (the "Joint Venture Agreement" with Hainan Savy Investment Management Ltd ("Hainan" and Mr. Thomas Knox ("Thomas Knox" , the Company's Non-executive Co-Chairman (Akers, Hainan and Thomas Knox together the "Parties" , to research, develop, produce and sell certain Akers' rapid diagnostic screening and testing products in China (the "Joint Venture" . The Joint Venture Company will be located in Haikou, the capital city of the province of Hainan, China, and is incorporated as Hainan Savy Akers Biosciences, Ltd.
AKER: 3.22 (+0.05), AKR: 31.73 (-0.70)
NETGEAR, Akers Biosciences, and TOP Ships to Appear on RedChip TV on Bloomberg
GlobeNewswire - Wed Oct 08, 10:46AM CDT
RedChip Companies, Inc. ("RedChip" , an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money"
TM) television program is featuring interviews with NETGEAR (Nasdaq:NTGR), Akers Biosciences (Nasdaq:AKER), and TOP Ships (Nasdaq:TOPS) this week on Bloomberg television.
TOPS: 1.29 (+0.07), AKER: 3.22 (+0.05), NTGR: 34.17 (-0.94)
Akers Biosciences Features on Global Broadcast & Online Media
GlobeNewswire - Tue Sep 16, 11:45AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that its Executive Chairman, Raymond F. Akers Jr., Ph.D, was featured on "The RedChip Money Report: Small Stocks Big Money" television program which was televised on Fox Business nationwide as well as Bloomberg Europe, UK and Asia. A recording of the globally transmitted interview regarding Akers Biosciences' business can be viewed here: http://youtu.be/5ymviBu1kno.
AKER: 3.22 (+0.05)
Police and Employers May Finally See Cannabis Breathalyzer
ACCESSWIRE - Wed Sep 10, 8:47AM CDT
Whitefish, MT / September 10, 2014 / The gradual proliferation of alcohol breathalyzer technology has helped bring down the per unit price so far that professional-grade technology, like the kind developed by Akers Biosciences, Inc. (NASDAQ: AKER), is now being marketed directly to consumers. Touted as a safety measure, as well as a means of avoiding the high cost and complications of a DUI/DWI, alcohol breathalyzers are becoming a proactive tool, used by consumers to help them more confidently enjoy an intoxicating product on their own terms.
AKER: 3.22 (+0.05), BED.VN: 0.770 (-0.010), TWD.VN: 1.950 (-0.040)
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Tue Sep 09, 1:34PM CDT
RedChip Companies, Inc. ("RedChip" , an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money" TM) television program will feature three companies on Fox Business nationwide on Tuesday, September 9 at 10:00 p.m. Pacific (1 a.m. EDT). The show will also air on Bloomberg Europe on Sunday, September 14 at 8:30 a.m. and 3:30 p.m. GMT; on Bloomberg U.K. Sunday, September 14 at 5:00 p.m. and 8:30 p.m. GMT; and on Bloomberg Asia on Sunday September 14 at 3:30 p.m. HKT.
IQNT: 17.72 (-0.35), AKER: 3.22 (+0.05)
Akers Biosciences Presenting at US Investor Conferences
GlobeNewswire - Tue Sep 09, 12:43PM CDT
Executive Chairman Raymond F. Akers Jr., Ph.D, to present at:
AKER: 3.22 (+0.05)
Akers Biosciences Announces $864,000 Sales Contract for Its Rapid Results Point of Care Cholesterol Test
GlobeNewswire - Tue Sep 09, 6:30AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI" , a leading designer and manufacturer of rapid diagnostic screening and testing products, announced a contract valued at $864,000 for sales of its innovative Tri-Cholesterol "Check" tests in Australia, Singapore, the United Arab Emirates and Oman. The Company's products are being distributed in such regions by 36 Strategies General Trading LLC ("36S" , a Dubai-based procurement solutions company. Target customers in Australia, Singapore, the United Arab Emirates and Oman include military forces, medical associations, universities and large companies operating in the resources sector.
AKER: 3.22 (+0.05)
Akers Biosciences Reports Its Second Quarter Financial Results
GlobeNewswire - Tue Aug 12, 6:09AM CDT
Sales of flagship PIFA Heparin/PF4 products increasing
AKER: 3.22 (+0.05)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 11:45AM CST
ALOG: 85.14 (-1.54), VBIV: 3.48 (-0.03), PRTK: 29.05 (+1.06), TPLM: 4.06 (-0.18), MIND: 5.92 (+0.17), SSE: 4.58 (-0.12), ALLT: 8.54 (+0.11), EGY: 4.49 (-0.06), GBR: 1.13 (+0.03), ECTE: 1.25 (-0.07), PWE: 2.15 (-0.06), GDP: 3.93 (-0.33), LAYN: 8.22 (+0.46), WRES: 1.32 (+0.03), CALA: 29.85 (+6.65), AKER: 3.22 (+0.05), CVEO: 7.81 (-0.15), CNIT: 4.30 (+0.09), CYRN: 1.80 (-0.16), CRK: 5.26 (-0.49)
Akers Biosciences Announces $1 Million Initial Order to Supply PIFA Heparin/PF4 Products to China
GlobeNewswire - Wed Dec 10, 6:00AM CST
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company"
, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces the receipt of an initial purchase order (the "Order" valued at US$1,000,000 from NovoTek Therapeutics Inc. ("NovoTek" to supply PIFA Heparin PF4/Rapid Assay products in Mainland China ("China" . AKER: 3.22 (+0.05)
Update: My Discussion With RedChip And Thoughts Going Forward
Daniel Ward - at Seeking Alpha - Mon Dec 08, 8:08AM CST
XBI: 183.73 (-0.31), AKER: 3.22 (+0.05), AEZS: 0.60 (+0.03)
Cannabis (MMJ) Breathalyzer Could Follow Vertical Path of Alcohol Breathalyzer
ACCESSWIRE - Tue Dec 02, 8:40AM CST
Whitefish, MT / ACCESSWIRE / December 2, 2014 / The effects of alcohol on a driver are well documented, with motor skills and often decision-making skills decreasing with each drink, subsequently increasing the likelihood of a fatal accident. A field sobriety test (i.e. walking heel-to-toe, follow a pen with eyes, stand on one foot) typically does an ample job at helping police officers identify a driver under the influence of alcohol, which is then typically followed by the tried-and-true alcohol breathalyzer test to pinpoint blood alcohol concentration (BAC). Although some laws and penalties vary from state to state, there is a nationwide standard of drunk driving being defined as BAC at or above 0.08 percent. Technological advancements have made alcohol breathalyzers affordably available to businesses and consumers, like Akers Biosciences' (NASDAQ: AKER) CHUBE and BreathScan products, to estimate BAC. Another portable BAC estimator, Breathometer's eponymous device that operates by attaching it to the audio output of a smart phone, garnered an aggregate $1 million in investments from all five "sharks" in April on the popular CNBC show "Shark Tank," lending to the idea that it is a growing industry against the backdrop of stiffening laws and greater awareness. Breathometer isn't alone in the smart phone breathalyzer space, orders are being taken for FLOOME, a universal smartphone accessory for measuring BAC developed with the help of Proto Labs (NYSE: PRLB).
PRLB: 67.04 (-0.01), AKER: 3.22 (+0.05)
Horrendous Stock Performance Of RedChip Nation Healthcare And Biotech Stocks
Daniel Ward - at Seeking Alpha - Mon Dec 01, 10:29AM CST
INO: 8.49 (+0.27), AKER: 3.22 (+0.05)
RedChip Issues Research Update on Akers Biosciences
GlobeNewswire - Tue Nov 18, 7:40AM CST
RedChip Companies, Inc., today announced it has issued a research update on Akers Biosciences Inc. (Nasdaq:AKER), a leading designer and manufacturer of rapid diagnostic screening and testing products.
AKER: 3.22 (+0.05)
Akers Biosciences Net Loss of $1.12M
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 6:18AM CST
AKER: 3.22 (+0.05)
Akers Biosciences Announces Its Financial Results for Third Quarter 2014
GlobeNewswire - Thu Nov 13, 6:05AM CST
Akers Biosciences, Inc. (Nasdaq:AKER), (the "Company" or "ABI"
, a leading designer and manufacturer of rapid diagnostic screening and testing products, reports its financial results for the third quarter ended September 30, 2014 and for the nine months ended September 30, 2014. The Form 10-Q containing the financial statements is available for viewing on the Company's website at www.akersbiosciences.com or www.sec.gov. AKER: 3.22 (+0.05)
Akers Biosciences Announces Conference Call to Discuss Its Third Quarter and Nine Months Financial Results
GlobeNewswire - Mon Nov 10, 6:07AM CST
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"
, a leading designer and manufacturer of rapid diagnostic screening and testing products, will hold a conference call on Thursday, November 13, 2014, at 10:30 a.m. Eastern Time to discuss its results for the third quarter and nine months ended September 30, 2014. AKER: 3.22 (+0.05)
The Perils Of Value Microcap Research And The Example Of Akers Biosciences
Daniel Ward - at Seeking Alpha - Tue Nov 04, 12:22PM CST
AKER: 3.22 (+0.05)
Week In Review: Roche Seeks China Partners With First-In-Class, Best-In-Class Products
ChinaBio Today - at Seeking Alpha - Sun Oct 26, 12:46PM CDT
Featured Companies In an exclusive interview, Dr. Darren Ji (Vice President and Global Head of Roche Partnering, Asia and Emerging Markets) told ChinaBio Today that Roche ( OTCQX:RHHBY ) ( OTCPK:RHHBF ) remains entirely focused on novel drugs for...
FMI: 21.52 (-0.31), AKER: 3.22 (+0.05), WX: 34.00 (+0.38)
Akers Biosciences Announces Joint Venture to Market Rapid Diagnostic Tests in China
GlobeNewswire - Thu Oct 23, 7:17AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"
, a leading designer and manufacturer of rapid diagnostic screening and testing products, has signed a Joint Venture Agreement (the "Joint Venture Agreement" with Hainan Savy Investment Management Ltd ("Hainan" and Mr. Thomas Knox ("Thomas Knox" , the Company's Non-executive Co-Chairman (Akers, Hainan and Thomas Knox together the "Parties" , to research, develop, produce and sell certain Akers' rapid diagnostic screening and testing products in China (the "Joint Venture" . The Joint Venture Company will be located in Haikou, the capital city of the province of Hainan, China, and is incorporated as Hainan Savy Akers Biosciences, Ltd. AKER: 3.22 (+0.05), AKR: 31.73 (-0.70)
NETGEAR, Akers Biosciences, and TOP Ships to Appear on RedChip TV on Bloomberg
GlobeNewswire - Wed Oct 08, 10:46AM CDT
RedChip Companies, Inc. ("RedChip"
, an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money" TM) television program is featuring interviews with NETGEAR (Nasdaq:NTGR), Akers Biosciences (Nasdaq:AKER), and TOP Ships (Nasdaq:TOPS) this week on Bloomberg television. TOPS: 1.29 (+0.07), AKER: 3.22 (+0.05), NTGR: 34.17 (-0.94)
Akers Biosciences Features on Global Broadcast & Online Media
GlobeNewswire - Tue Sep 16, 11:45AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that its Executive Chairman, Raymond F. Akers Jr., Ph.D, was featured on "The RedChip Money Report: Small Stocks Big Money" television program which was televised on Fox Business nationwide as well as Bloomberg Europe, UK and Asia. A recording of the globally transmitted interview regarding Akers Biosciences' business can be viewed here: http://youtu.be/5ymviBu1kno.
AKER: 3.22 (+0.05)
Police and Employers May Finally See Cannabis Breathalyzer
ACCESSWIRE - Wed Sep 10, 8:47AM CDT
Whitefish, MT / September 10, 2014 / The gradual proliferation of alcohol breathalyzer technology has helped bring down the per unit price so far that professional-grade technology, like the kind developed by Akers Biosciences, Inc. (NASDAQ: AKER), is now being marketed directly to consumers. Touted as a safety measure, as well as a means of avoiding the high cost and complications of a DUI/DWI, alcohol breathalyzers are becoming a proactive tool, used by consumers to help them more confidently enjoy an intoxicating product on their own terms.
AKER: 3.22 (+0.05), BED.VN: 0.770 (-0.010), TWD.VN: 1.950 (-0.040)
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Tue Sep 09, 1:34PM CDT
RedChip Companies, Inc. ("RedChip"
, an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money" TM) television program will feature three companies on Fox Business nationwide on Tuesday, September 9 at 10:00 p.m. Pacific (1 a.m. EDT). The show will also air on Bloomberg Europe on Sunday, September 14 at 8:30 a.m. and 3:30 p.m. GMT; on Bloomberg U.K. Sunday, September 14 at 5:00 p.m. and 8:30 p.m. GMT; and on Bloomberg Asia on Sunday September 14 at 3:30 p.m. HKT. IQNT: 17.72 (-0.35), AKER: 3.22 (+0.05)
Akers Biosciences Presenting at US Investor Conferences
GlobeNewswire - Tue Sep 09, 12:43PM CDT
Executive Chairman Raymond F. Akers Jr., Ph.D, to present at:
AKER: 3.22 (+0.05)
Akers Biosciences Announces $864,000 Sales Contract for Its Rapid Results Point of Care Cholesterol Test
GlobeNewswire - Tue Sep 09, 6:30AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"
, a leading designer and manufacturer of rapid diagnostic screening and testing products, announced a contract valued at $864,000 for sales of its innovative Tri-Cholesterol "Check" tests in Australia, Singapore, the United Arab Emirates and Oman. The Company's products are being distributed in such regions by 36 Strategies General Trading LLC ("36S" , a Dubai-based procurement solutions company. Target customers in Australia, Singapore, the United Arab Emirates and Oman include military forces, medical associations, universities and large companies operating in the resources sector. AKER: 3.22 (+0.05)
Akers Biosciences Reports Its Second Quarter Financial Results
GlobeNewswire - Tue Aug 12, 6:09AM CDT
Sales of flagship PIFA Heparin/PF4 products increasing
AKER: 3.22 (+0.05)
